How much does Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) cost?

Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) is a fixed-dose combination that can be used with chemotherapy to treat certain types of early-stage breast cancer that have spread to nearby tissue. It is also used to treat certain types of early-stage breast cancer to reduce the chance of certain types of breast cancer coming back. Phesgo is also used with docetaxel to treat certain types of breast cancer that have spread to other parts of the body. Pertuzumabandtrastuzumabbelong to a class of drugs called monoclonal antibodies. They work by stopping the growth of cancer cells. Hyaluronidase is an endoglycosidase. It helps pertuzumab and trastuzumab stay in the body longer so these drugs can work more effectively.

Phesgo is a liquid injected under the skin, given by a doctor or nurse in a hospital or medical facility. It is usually injected once every 3 weeks, with each injection lasting 5-8 minutes. The length of treatment will depend on the patient's condition and the body's response to treatment. Your doctor or nurse will monitor you closely during treatment and tell your doctor or nurse immediately if you develop any symptoms, which may include fever, chills, nausea, vomiting, diarrhea, rash, hives, itching, swelling of the face, eyes, mouth, throat, tongue or lips, difficulty breathing or swallowing, or chest pain.

The original Phesgo drug is not marketed in the country and therefore cannot be included in medical insurance. Since Phesgo's original drug has been on the market overseas for a short time, there is less price and other related information. For specific prices and drug information, please consult Yaode's medical consultant.